Automating Assay Development for Early Stage Drug Discovery
Likarda works with clients at the early stages of drug development and discovery. Dr Lisa Stehno-Bittel, President & Co-founder of Likarda, discusses how the company develops 3D cell clusters, which are indicative of native tissues in the body, for use in cell-based assays. Hear from research scientist Stephen Harrington PhD, Likarda’s Director of Production, how the team has utilized automation to increase throughput and reproducibility, most recently employing the Integra Assist to bridge the gap between manual bench work and complete automation.
Thank you to our friends at SelectScience.net for a great video and our partners, Integra Biosciences for helping us implement cutting-edge technology that brings speed, flexibility and precision to the Likarda labs.